Boyd Watterson Asset Management LLC Pfizer Inc Transaction History

Boyd Watterson Asset Management LLC

$331 Million
Q3 2025

A detailed history of Boyd Watterson Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 13,208 shares of PFE stock, worth $331,256. This represents 0.1% of its overall portfolio holdings.

Number of Shares

13,208

Previous 13,878 4.83%

Holding current value

$331,256

Previous $336,000 -0.0%

% of portfolio

0.1%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$23.29 - $25.88 $15,604 - $17,339	-670 Reduced 4.83%	13,208 $336,000
Q2 2025 Aug 01, 2025	SELL	$21.59 - $24.84 $164,602 - $189,380	-7,624 Reduced 35.46%	13,878 $336,000
Q1 2025 May 06, 2025	SELL	$25.01 - $27.13 $300 - $325	-12 Reduced 0.06%	21,502 $544,000
Q4 2024 Feb 03, 2025	SELL	$24.8 - $30.19 $768 - $935	-31 Reduced 0.14%	21,514 $570,000
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $1,412 - $1,600	-51 Reduced 0.24%	21,545 $623,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $189,450 - $222,000	-7,500 Reduced 25.78%	21,596 $604,000
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $302,913 - $347,841	-11,700 Reduced 28.68%	29,096 $807,000
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $523,958 - $680,564	-20,052 Reduced 32.95%	40,796 $1.17 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $686 - $794	19 Added 0.03%	60,848 $2.23 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $669 - $871	17 Added 0.03%	60,829 $2.48 Million
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $1,252 - $1,635	-30 Reduced 0.05%	60,812 $0
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $2,605 - $3,089	-56 Reduced 0.09%	60,842 $3.19 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $1,235 - $1,530	27 Added 0.04%	60,898 $3.15 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $578 - $857	-14 Reduced 0.02%	60,871 $3.59 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $353 - $453	-9 Reduced 0.01%	60,885 $2.62 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $3,339 - $3,783	93 Added 0.15%	60,894 $2.39 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $4,889 - $5,514	-146 Reduced 0.24%	60,801 $2.2 Million
Q4 2020 Jan 20, 2021	SELL	$33.47 - $42.56 $13,421 - $17,066	-401 Reduced 0.65%	60,947 $2.24 Million
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $17,272 - $20,264	-544 Reduced 0.88%	61,348 $2.25 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $15,060 - $18,270	-500 Reduced 0.8%	61,892 $2.02 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $891 - $1,274	-33 Reduced 0.05%	62,392 $2.04 Million
Q4 2019 Jan 16, 2020	SELL	$32.92 - $37.36 $13,168 - $14,944	-400 Reduced 0.64%	62,425 $2.45 Million
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $324,900 - $421,300	-10,000 Reduced 13.73%	62,825 $2.26 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $30,582 - $34,337	-827 Reduced 1.12%	72,825 $3.16 Million
Q1 2019 Apr 09, 2019	BUY	$37.5 - $41.2 $24,825 - $27,274	662 Added 0.91%	73,652 $3.13 Million
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $10,156 - $11,579	-264 Reduced 0.36%	72,990 $3.19 Million
Q3 2018 Oct 17, 2018	SELL	$34.47 - $41.81 $6,825 - $8,278	-198 Reduced 0.27%	73,254 $3.23 Million
Q2 2018 Jul 18, 2018	SELL	$32.98 - $35.16 $325,809 - $347,345	-9,879 Reduced 11.86%	73,452 $2.67 Million
Q1 2018 Apr 19, 2018	BUY	$31.91 - $37.02 $270,277 - $313,559	8,470 Added 11.31%	83,331 $2.96 Million
Q4 2017 Jan 11, 2018	SELL	$33.26 - $35.29 $23,248 - $24,667	-699 Reduced 0.93%	74,861 $2.71 Million
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $2.34 Million - $2.58 Million	75,560	75,560 $2.7 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.57B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.

Account

Boyd Watterson Asset Management LLC Pfizer Inc Transaction History